bioMerieux S.A. (BIM)-Product Pipeline Analysis, 2017 Update

bioMerieux S.A. (BIM)-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME643PD
  • |
  • Pages: 63
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiovascular diseases and targeted cancers. The company also provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for agri-food, cosmetics and pharmaceutical industries. The company conducts its operations through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy l'Etoile, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company bioMerieux S.A.

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

bioMerieux S.A. Company Overview 6

bioMerieux S.A. Company Snapshot 6

bioMerieux S.A. Pipeline Products and Ongoing Clinical Trials Overview 6

bioMerieux S.A.-Pipeline Analysis Overview 9

Business Description 9

bioMerieux S.A.-Key Facts 9

bioMerieux S.A.-Major Products and Services 10

bioMerieux S.A. Pipeline Products by Development Stage 12

bioMerieux S.A. Ongoing Clinical Trials by Trial Status 15

bioMerieux S.A. Pipeline Products Overview 17

Annexin A3 Prostate Cancer Marker 17

Annexin A3 Prostate Cancer Marker Product Overview 17

BRAF-Breast Cancer Diagnostic Kit 18

BRAF-Breast Cancer Diagnostic Kit Product Overview 18

CancerTARGET ID 19

CancerTARGET ID Product Overview 19

CancerTREATMENT ID 20

CancerTREATMENT ID Product Overview 20

CancerTYPE ID 21

CancerTYPE ID Product Overview 21

Companion Diagnostic Test-Hormone-Dependent Breast Cancer 22

Companion Diagnostic Test-Hormone-Dependent Breast Cancer Product Overview 22

Companion Diagnostic Test-Hormone-Dependent Neuro Endocrine Tumor 23

Companion Diagnostic Test-Hormone-Dependent Neuro Endocrine Tumor Product Overview 23

Companion Diagnostic Test-Hormone-Dependent Pituitary Tumor 24

Companion Diagnostic Test-Hormone-Dependent Pituitary Tumor Product Overview 24

Companion Diagnostic Test-Hormone-Dependent Prostate Cancer 25

Companion Diagnostic Test-Hormone-Dependent Prostate Cancer Product Overview 25

Diagnostic Assay-Prostate Cancer 26

Diagnostic Assay-Prostate Cancer Product Overview 26

Diagnostic Test-Colorectal Cancer 27

Diagnostic Test-Colorectal Cancer Product Overview 27

Diagnostic Test-Tuberculosis 28

Diagnostic Test-Tuberculosis Product Overview 28

FilmArray Biothreat-E Test 29

FilmArray Biothreat-E Test Product Overview 29

FilmArray Direct Sepsis Panel 30

FilmArray Direct Sepsis Panel Product Overview 30

FilmArray Febrile Infant Panel 31

FilmArray Febrile Infant Panel Product Overview 31

FilmArray Febrile Infant Panel Clinical Trial 32

FilmArray NGDS BT-E Assay 33

FilmArray NGDS BT-E Assay Product Overview 33

FilmArray Pneumonia Pathogen Panel 34

FilmArray Pneumonia Pathogen Panel Product Overview 34

FilmArray STD Panel 35

FilmArray STD Panel Product Overview 35

iMAG 36

iMAG Product Overview 36

Magnotech System 37

Magnotech System Product Overview 37

Magnotech System-Cardiovascular Disease Assay 38

Magnotech System-Cardiovascular Disease Assay Product Overview 38

NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test 39

NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Overview 39

NucliSENS EasyQ Legionella spp Molecular Test 40

NucliSENS EasyQ Legionella spp Molecular Test Product Overview 40

NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test 41

NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Overview 41

VIDAS CRP Assay 42

VIDAS CRP Assay Product Overview 42

bioMerieux S.A.-Key Competitors 43

bioMerieux S.A.-Key Employees 44

bioMerieux S.A.-Key Employee Biographies 46

bioMerieux S.A.-Locations And Subsidiaries 47

Head Office 47

Other Locations & Subsidiaries 47

Recent Developments 52

bioMerieux S.A., Recent Developments 52

Jun 08, 2017: New Data From Biotheranostics Further Demonstrate the Value of CancerTYPE ID to Help Identify Metastatic Cancers with an Unknown or Unclear Tumor Type Diagnosis 52

Jun 05, 2017: New Data Affirms Value of Breast Cancer Index (BCI) in Identification of Early Stage ER+ Breast Cancer Patients Appropriate for Extended Endocrine Therapy 52

Jun 01, 2017: bioMerieux receives FDA Clearance for BioFire's FilmArray Respiratory Panel 2 (RP2) 53

May 18, 2017: Biotheranostics Appoints Don Hardison as New Chief Executive Officer 53

May 02, 2017: Biotheranostics Presents First Data from the BCI Clinical Database for Correlative Studies 54

Apr 20, 2017: bioMerieux-First-Quarter 2017 Business Review 55

Apr 05, 2017: bioMerieux receives FDA 510(k) clearance for its BacT/ALERT VIRTUO fully automated blood culture system 57

Mar 15, 2017: Breast Cancer Index (BCI) Included in Updated Guidelines for Use of Clinical Biomarkers in Breast Cancer 57

Mar 10, 2017: Study Demonstrates Use of Breast Cancer Index Leads to Significant Changes in Physician Recommendations for Extended Endocrine Therapy in ER+ Breast Cancer Patients 58

Feb 24, 2017: bioMerieux's VIDAS B.R.A.H.M.S PCT becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis 59

Appendix 60

Methodology 60

About GlobalData 62

Contact Us 62

Disclaimer 62

List of Figures

bioMerieux S.A. Pipeline Products by Equipment Type 7

bioMerieux S.A. Pipeline Products by Development Stage 12

bioMerieux S.A. Ongoing Clinical Trials by Trial Status 15

List of Tables

bioMerieux S.A. Pipeline Products and Ongoing Clinical Trials Overview 6

bioMerieux S.A. Pipeline Products by Equipment Type 7

bioMerieux S.A. Pipeline Products by Indication 8

bioMerieux S.A. Ongoing Clinical Trials by Trial Status 8

bioMerieux S.A., Key Facts 9

bioMerieux S.A., Major Products and Services 10

bioMerieux S.A. Number of Pipeline Products by Development Stage 12

bioMerieux S.A. Pipeline Products Summary by Development Stage 13

bioMerieux S.A. Ongoing Clinical Trials by Trial Status 15

bioMerieux S.A. Ongoing Clinical Trials Summary 16

Annexin A3 Prostate Cancer Marker-Product Status 17

Annexin A3 Prostate Cancer Marker-Product Description 17

BRAF-Breast Cancer Diagnostic Kit-Product Status 18

BRAF-Breast Cancer Diagnostic Kit-Product Description 18

CancerTARGET ID-Product Status 19

CancerTARGET ID-Product Description 19

CancerTREATMENT ID-Product Status 20

CancerTREATMENT ID-Product Description 20

CancerTYPE ID-Product Status 21

CancerTYPE ID-Product Description 21

Companion Diagnostic Test-Hormone-Dependent Breast Cancer-Product Status 22

Companion Diagnostic Test-Hormone-Dependent Breast Cancer-Product Description 22

Companion Diagnostic Test-Hormone-Dependent Neuro Endocrine Tumor-Product Status 23

Companion Diagnostic Test-Hormone-Dependent Neuro Endocrine Tumor-Product Description 23

Companion Diagnostic Test-Hormone-Dependent Pituitary Tumor-Product Status 24

Companion Diagnostic Test-Hormone-Dependent Pituitary Tumor-Product Description 24

Companion Diagnostic Test-Hormone-Dependent Prostate Cancer-Product Status 25

Companion Diagnostic Test-Hormone-Dependent Prostate Cancer-Product Description 25

Diagnostic Assay-Prostate Cancer-Product Status 26

Diagnostic Assay-Prostate Cancer-Product Description 26

Diagnostic Test-Colorectal Cancer-Product Status 27

Diagnostic Test-Colorectal Cancer-Product Description 27

Diagnostic Test-Tuberculosis-Product Status 28

Diagnostic Test-Tuberculosis-Product Description 28

FilmArray Biothreat-E Test-Product Status 29

FilmArray Biothreat-E Test-Product Description 29

FilmArray Direct Sepsis Panel-Product Status 30

FilmArray Direct Sepsis Panel-Product Description 30

FilmArray Febrile Infant Panel-Product Status 31

FilmArray Febrile Infant Panel-Product Description 31

FilmArray Febrile Infant Panel-Pilot Evaluation of the FilmArray Febrile Infant (FI) Panel 32

FilmArray NGDS BT-E Assay-Product Status 33

FilmArray NGDS BT-E Assay-Product Description 33

FilmArray Pneumonia Pathogen Panel-Product Status 34

FilmArray Pneumonia Pathogen Panel-Product Description 34

FilmArray STD Panel-Product Status 35

FilmArray STD Panel-Product Description 35

iMAG-Product Status 36

iMAG-Product Description 36

Magnotech System-Product Status 37

Magnotech System-Product Description 37

Magnotech System-Cardiovascular Disease Assay-Product Status 38

Magnotech System-Cardiovascular Disease Assay-Product Description 38

NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test-Product Status 39

NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test-Product Description 39

NucliSENS EasyQ Legionella spp Molecular Test-Product Status 40

NucliSENS EasyQ Legionella spp Molecular Test-Product Description 40

NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test-Product Status 41

NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test-Product Description 41

VIDAS CRP Assay-Product Status 42

VIDAS CRP Assay-Product Description 42

bioMerieux S.A., Key Employees 44

bioMerieux S.A., Key Employee Biographies 46

bioMerieux S.A., Other Locations 47

bioMerieux S.A., Subsidiaries 47

Glossary 61

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

bioMerieux S.A., Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 48263
Site License
USD 1500 INR 96525
Corporate User License
USD 2250 INR 144788

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com